Sigmascreening is a medical device company based in Amsterdam that specializes in creating innovative products for breast cancer screening. Established in 2010 as a spin-off from the Academic Medical Center Amsterdam (AMC Amsterdam), the company is dedicated to enhancing digital mammography, the standard method for breast cancer detection. Sigmascreening is actively working on several new developments to make significant improvements in this crucial area of healthcare. The company received a €1.00M Venture Round investment on 23 June 2015 from DFZ Participaties.
No recent news or press coverage available for Sigmascreening.